Armstrong strain lymphocytic choriomeningitis virus infection after accidental laboratory exposure

Laurence Caron1,2, Jean-Sébastien Delisle2,3, James E Strong4,5,6

  • 1Département de microbiologie, infectiologie et immunologie, Université de Montréal, Montréal, QC, Canada.

Virology Journal
|December 13, 2023
PubMed
Abstract

Insights

Accidental exposure to Lymphocytic choriomeningitis virus (LCMV) Armstrong in a lab setting resulted in mild symptoms. This case highlights the importance of recognizing LCMV Armstrong infection symptoms in researchers.

Area of Science:

  • Virology
  • Immunology
  • Public Health

Background:

  • Lymphocytic choriomeningitis virus (LCMV) is a rodent-borne pathogen utilized in immunological research.
  • LCMV Armstrong and Clone-13 strains cause distinct infections in mice.
  • Laboratory personnel face risks of human infection due to LCMV's widespread research use.

Observation:

  • A researcher experienced percutaneous exposure to LCMV Armstrong.
  • Symptoms included headaches, dizziness, eye pain, and nausea, appearing seven days post-exposure.
  • Antibody development (IgM and IgG) and full recovery were documented within three months.

Findings:

  • This is the first reported accidental human infection with LCMV Armstrong.
  • Symptoms differed from LCMV Clone-13 infections, notably lacking fever and vomiting but including leg numbness.
  • The case provides crucial data on LCMV Armstrong's clinical presentation in humans.

Implications:

  • Enhances understanding of LCMV Armstrong infection symptoms in humans.
  • Aids clinicians and public health officials in diagnosing and managing accidental LCMV exposures.
  • Informs safety protocols and counseling for laboratory workers handling LCMV.